Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net loss     $ (21,399,165) $ (30,476,921)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss on foreign exchange     72,186 16,953  
Amortization of loan costs       52,373  
Depreciation       2,063  
Reduction in carrying amount of right-of-use asset     50,030 49,553  
Loss on debt conversion with related party       6,134,120  
Acquisition of license for research and development       12,030,667  
Deferred tax (benefit) expense $ (839) $ (1,436) (2,480,340) 189,255  
IPR&D impairment 0   9,190,897   $ 0
Share-based compensation expense     1,551,025 197,782  
Changes in operating assets and liabilities:          
Decrease in prepaid expenses and other current assets     968,527 168,873  
Decrease in accounts payable     (572,035) (651,572)  
(Decrease) increase in accrued expenses and other liabilities     (215,768) 305,390  
Net cash used in operating activities     (12,834,643) (11,981,464)  
Cash flows from financing activities          
Proceeds from registered direct offering of common stock, net of offering costs     11,397,459 4,252,245  
Proceeds from the exercise of prefunded warrants     205    
Payment of issuance costs     (106,266)    
Proceeds from loan with related party       3,000,000  
Net cash provided by financing activities     11,291,398 7,252,245  
Net decrease in cash     (1,543,245) (4,729,219)  
Cash, beginning of period     6,524,744 14,847,949 14,847,949
Effect of foreign currency translation on cash     (33,233) 7,980  
Cash, end of period $ 4,948,266 $ 10,126,710 $ 4,948,266 10,126,710 $ 6,524,744
Supplemental disclosure of non-cash financing and investing activities:          
Legal costs related to the License Agreement included in accrued expenses       121,000  
Conversion of debt with related party into Series A-1 Non-Voting Convertible Preferred Stock       19,500,000  
Conversion of accrued interest on debt with related party into Series A-1 Non-Voting Convertible Preferred Stock       426,891  
Conversion of Series A Non-Voting Convertible Preferred Stock from temporary equity to permanent equity       5,535,067  
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock       1,256,662  
Preferred stock issued in connection with License Agreement       9,800,839  
Common stock issued in connection with License Agreement       $ 2,108,828